- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07942870
Superior Trunk Block Versus Combined Suprascapular and Axillary Nerve Blocks
Ultrasound-Guided Superior Trunk Block Versus Combined Suprascapular and Axillary Nerve Blocks on Diaphragmatic Function and Postoperative Analgesia in Patients Undergoing Arthroscopic Shoulder Surgery
This randomized controlled trial aims to compare the effects of ultrasound-guided superior trunk block versus combined suprascapular and axillary nerve blocks on diaphragmatic function and postoperative analgesia in patients undergoing arthroscopic shoulder surgery.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Arthroscopic shoulder surgery is associated with significant postoperative pain. The interscalene brachial plexus block is effective but carries a risk of hemidiaphragmatic paralysis.
The superior trunk block targets the C5-C6 roots after they form the superior trunk and aims to reduce phrenic nerve involvement. Combined blockade of the suprascapular and axillary nerves provides shoulder analgesia with potentially less diaphragmatic impact.
This study will randomize patients undergoing elective unilateral arthroscopic shoulder surgery to receive either ultrasound-guided superior trunk block or combined ultrasound-guided suprascapular and axillary nerve blocks, and will assess diaphragmatic function and postoperative pain.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Tarek A Sayed, Resident
- Phone Number: 0109876361
- Email: Tarek.18313300@med.aun.edu.eg
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- American Society of Anesthesiologists physical status I-II
- Age 18-65 years
- Scheduled for elective unilateral arthroscopic shoulder surgery
- Written informed consent
Exclusion Criteria:
- Patient refusal
- Known allergy to local anesthetics
- Pre-existing phrenic nerve palsy or diaphragmatic dysfunction
- Severe chronic obstructive pulmonary disease
- Coagulopathy or bleeding diathesis
- Infection at the injection site
- Pre-existing neurological deficit in the operative arm
- Pregnancy or breastfeeding
- Body mass index greater than 35 kg/m²
- Bilateral shoulder surgery
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Superior Trunk Block
Patients will receive ultrasound-guided superior trunk block with 10 mL of 0.25% bupivacaine. |
Ultrasound-guided injection of local anesthetic around the superior trunk of the brachial plexus. |
|
Active Comparator: Combined Suprascapular and Axillary Nerve Blocks
Patients will receive combined ultrasound-guided suprascapular and axillary nerve blocks with 5 mL of 0.5% ropivacaine for each nerve (total 10 mL). |
Ultrasound-guided injection of local anesthetic around the suprascapular nerve and the axillary nerve. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of patients with hemidiaphragmatic paralysis
Time Frame: At 30 minutes after block
|
Number of patients who develop hemidiaphragmatic paralysis assessed by ultrasound measurement of diaphragmatic excursion at 30 minutes after the block. |
At 30 minutes after block
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diaphragmatic excursion
Time Frame: At 30 minutes after block
|
Mean diaphragmatic excursion measured by ultrasound in centimeters during quiet breathing and deep inspiration. |
At 30 minutes after block
|
|
Pain score at rest
Time Frame: At 24 hours
|
Mean pain score at rest measured by numerical rating scale (range 0 to 10, higher scores indicate more pain). |
At 24 hours
|
|
Total opioid consumption
Time Frame: At 24 hours
|
Mean total opioid consumption in morphine milligram equivalents in the first 24 hours after surgery. |
At 24 hours
|
|
Time to first rescue analgesia
Time Frame: At 24 hours
|
Mean time from end of surgery to first request for rescue analgesia in hours. |
At 24 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Samy A Amr, prof, Anaesthesia , ICU and pain management Department, Assiut University Hospitals
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STB-vs-SSANB-Shoulder-Assiut
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.